Literature DB >> 18343928

Murine liver implantation of radiation-induced fibrosarcoma: characterization with MR imaging, microangiography and histopathology.

Huaijun Wang1, Marie Van de Putte, Feng Chen, Frederik De Keyzer, Lixin Jin, Jie Yu, Guy Marchal, Peter de Witte, Yicheng Ni.   

Abstract

We sought to establish and characterize a mouse liver tumor model as a platform for preclinical assessment of new diagnostics and therapeutics. Radiation-induced fibrosarcoma (RIF-1) was intrahepatically implanted in 27 C3H/Km mice. Serial in vivo magnetic resonance imaging (MRI) with a clinical 1.5-T-magnet was performed using T1- (T1WI), T2- (T2WI), and diffusion-weighted sequences (DWI), dynamic contrast-enhanced MRI (DCE-MRI), and contrast-enhanced T1WI, and validated with postmortem microangiography and histopathology. Implantation procedure succeeded in 25 mice with 2 deaths from overdosed anesthesia or hypothermia. RIF-1 grew in 21 mice with volume doubling time of 2.55+/-0.88 days and final size of 216.2+/-150.4 mm(3) at day 14. Three mice were found without tumor growth and one only with abdominal seeding. The intrahepatic RIF-1 was hypervascularized with negligible necrosis as shown on MRI, microangiography and histology. On DCE-MRI, maximal initial slope of contrast-time curve and volume transfer constant per unit volume of tissue, K, differed between the tumor and liver with only the former significantly lower in the tumor than in the liver (P<0.05). Liver implantation of RIF-1 in mice proves a feasible and reproducible model and appears promising for use to screen new diagnostics and therapeutics under noninvasive monitoring even with a clinical MRI system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18343928     DOI: 10.1007/s00330-008-0904-2

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   7.034


  27 in total

1.  MR imaging of biodegradable polymeric microparticles: a potential method of monitoring local drug delivery.

Authors:  Hunter H Chen; Catherine Le Visage; Bensheng Qiu; Xiangying Du; Ronald Ouwerkerk; Kam W Leong; Xiaoming Yang
Journal:  Magn Reson Med       Date:  2005-03       Impact factor: 4.668

Review 2.  Building 'validated' mouse models of human cancer.

Authors:  B Hann; A Balmain
Journal:  Curr Opin Cell Biol       Date:  2001-12       Impact factor: 8.382

3.  Early reoxygenation in tumors after irradiation: determining factors and consequences for radiotherapy regimens using daily multiple fractions.

Authors:  Nathalie Crokart; Bénédicte F Jordan; Christine Baudelet; Reginald Ansiaux; Pierre Sonveaux; Vincent Grégoire; Nelson Beghein; Julie DeWever; Caroline Bouzin; Olivier Feron; Bernard Gallez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-11-01       Impact factor: 7.038

4.  Synergistic effect of interstitial laser coagulation and doxorubicin in a murine tumor recurrence model of solitary colorectal liver metastasis.

Authors:  Liesbeth M Veenendaal; Richard van Hillegersberg; Niels Smakman; Jarmila D W van der Bilt; Paul J van Diest; Onno Kranenburg; Inne H M Borel Rinkes
Journal:  Ann Surg Oncol       Date:  2006-01-20       Impact factor: 5.344

5.  In vivo multiple-mouse imaging at 1.5 T.

Authors:  S Xu; T P F Gade; C Matei; K Zakian; A A Alfieri; X Hu; E C Holland; S Soghomonian; J Tjuvajev; D Ballon; J A Koutcher
Journal:  Magn Reson Med       Date:  2003-03       Impact factor: 4.668

6.  Hypericin as a marker for determination of tissue viability after intratumoral ethanol injection in a murine liver tumor model.

Authors:  Marie Van de Putte; Huaijun Wang; Feng Chen; Peter A M de Witte; Yicheng Ni
Journal:  Acad Radiol       Date:  2008-01       Impact factor: 3.173

7.  A new mouse tumor model system (RIF-1) for comparison of end-point studies.

Authors:  P R Twentyman; J M Brown; J W Gray; A J Franko; M A Scoles; R F Kallman
Journal:  J Natl Cancer Inst       Date:  1980-03       Impact factor: 13.506

8.  High-resolution assessment of blood flow in murine RIF-1 tumors by monitoring uptake of H(2)(17)O with proton T(1rho)-weighted imaging.

Authors:  Dharmesh R Tailor; Harish Poptani; Jerry D Glickson; John S Leigh; Ravinder Reddy
Journal:  Magn Reson Med       Date:  2003-01       Impact factor: 4.668

9.  Multiple-mouse MRI.

Authors:  Nicholas A Bock; Norman B Konyer; R Mark Henkelman
Journal:  Magn Reson Med       Date:  2003-01       Impact factor: 4.668

10.  31P-magnetic resonance spectroscopy and 2H-magnetic resonance imaging studies of a panel of early-generation transplanted murine tumour models.

Authors:  S P Robinson; A van den Boogaart; R J Maxwell; J R Griffiths; E Hamilton; J C Waterton
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

View more
  9 in total

Review 1.  Mammalian models of chemically induced primary malignancies exploitable for imaging-based preclinical theragnostic research.

Authors:  Yewei Liu; Ting Yin; Yuanbo Feng; Marlein Miranda Cona; Gang Huang; Jianjun Liu; Shaoli Song; Yansheng Jiang; Qian Xia; Johannes V Swinnen; Guy Bormans; Uwe Himmelreich; Raymond Oyen; Yicheng Ni
Journal:  Quant Imaging Med Surg       Date:  2015-10

2.  Dynamic contrast enhanced MR imaging for evaluation of angiogenesis of hepatocellular nodules in liver cirrhosis in N-nitrosodiethylamine induced rat model.

Authors:  Wei Zhang; Hui Juan Chen; Zhen J Wang; Wei Huang; Long Jiang Zhang
Journal:  Eur Radiol       Date:  2016-08-03       Impact factor: 5.315

Review 3.  Whole animal imaging.

Authors:  Gurpreet Singh Sandhu; Luis Solorio; Ann-Marie Broome; Nicolas Salem; Jeff Kolthammer; Tejas Shah; Chris Flask; Jeffrey L Duerk
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 Jul-Aug

4.  Feng Chen's work on translational and clinical imaging.

Authors:  Feng Chen
Journal:  World J Radiol       Date:  2011-04-28

5.  In vivo imaging of pancreatic tumours and liver metastases using 7 Tesla MRI in a murine orthotopic pancreatic cancer model and a liver metastases model.

Authors:  Ivo L Partecke; André Kaeding; Matthias Sendler; Nele Albers; Jens-P Kühn; Sven Speerforck; Sebastian Roese; Florian Seubert; Stephan Diedrich; Sandra Kuehn; Ulrich F Weiss; Julia Mayerle; Markus M Lerch; Stefan Hadlich; Norbert Hosten; Claus-D Heidecke; Ralf Puls; Wolfram von Bernstorff
Journal:  BMC Cancer       Date:  2011-01-28       Impact factor: 4.430

6.  Mouse Hepatic Tumor Vascular Imaging by Experimental Selective Angiography.

Authors:  Sang Kyum Kim; Honsoul Kim; Gou Young Koh; Dae-Sik Lim; Dae-Yeul Yu; Man Deuk Kim; Mi-Suk Park; Joon Seok Lim
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

7.  Application of 3.0 tesla magnetic resonance imaging for diagnosis in the orthotopic nude mouse model of pancreatic cancer.

Authors:  Li Wu; Chen Wang; Xiuzhong Yao; Kai Liu; Yanjun Xu; Haitao Zhang; Caixia Fu; Xiaolin Wang; Yingyi Li
Journal:  Exp Anim       Date:  2014-07-22

Review 8.  Predicting Clinical Efficacy of Vascular Disrupting Agents in Rodent Models of Primary and Secondary Liver Cancers: An Overview with Imaging-Histopathology Correlation.

Authors:  Yewei Liu; Shuncong Wang; Xiaohui Zhao; Yuanbo Feng; Guy Bormans; Johan Swinnen; Raymond Oyen; Gang Huang; Yicheng Ni; Yue Li
Journal:  Diagnostics (Basel)       Date:  2020-01-31

9.  Intra-individual comparison of therapeutic responses to vascular disrupting agent CA4P between rodent primary and secondary liver cancers.

Authors:  Ye-Wei Liu; Frederik De Keyzer; Yuan-Bo Feng; Feng Chen; Shao-Li Song; Johan Swinnen; Guy Bormans; Raymond Oyen; Gang Huang; Yi-Cheng Ni
Journal:  World J Gastroenterol       Date:  2018-07-07       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.